This is a dummy test for home page
BAGHDAD (Reuters) – The United Nations Children’s Fund UNICEF appealed on Wednesday for $17 million to help rebuild Iraq’s health facilities, ahead of an international conference to support the country’s reconstruction due to convene next week in Kuwait.
Source: Reuters Medical News
(Reuters) – Gilead Sciences Inc on Tuesday said fourth-quarter sales of its flagship hepatitis C drugs fell by more than half amid increased competition, and the company forecast a further slowdown for the current year.
Source: Reuters Medical News
(Reuters Health) – Flu shots may be especially important for older women who are socially active, a study from Japan suggests.
Source: Reuters Medical News
(Reuters Health) – Women who develop high blood pressure during pregnancy may have the condition reappear within a year of delivery, and many of them may go undiagnosed because the problem only surfaces at night, a new study suggests.
Source: Reuters Medical News
(Reuters Health) – As many as one in 10 U.S. children may have fetal alcohol spectrum disorders, far more than previously thought, a new study of first graders suggests.
Source: Reuters Medical News
(Reuters Health) – Parents of kids with food allergies often engage in behaviors that could trigger an allergic reaction in their child, a survey found.
Source: Reuters Medical News
(Reuters) – A combination of experimental drugs from Array BioPharma Inc kept patients with advanced melanoma associated with a common gene mutation alive for nearly three years and twice as long as a rival Roche Holding AG medicine, according to data from a late stage study released on Tuesday.
Source: Reuters Medical News
LONDON (Reuters) – After nearly a century building a company worth $125 billion based on injectable drugs, Denmark’s Novo Nordisk – the world’s biggest insulin maker – wants to prove this year it can transform the diabetes market with a pill.
Source: Reuters Medical News
(Reuters) – Allergan Plc on Tuesday reported better-than-expected quarterly profit on robust demand for Botox, boosted its earnings forecast and announced positive data on one of the two migraine treatments it is developing.
Source: Reuters Medical News
ZURICH (Reuters) – Roche’s Tecentriq mixed with an older drug cut the risk of death in kidney cancer, marking another win for the Swiss drugmaker’s immuno-oncology (I/O) cocktail as it battles better-established medicines made by its rivals.
Source: Reuters Medical News